[go: up one dir, main page]

DE102004016605A1 - Thiocarbamoylproline - Google Patents

Thiocarbamoylproline Download PDF

Info

Publication number
DE102004016605A1
DE102004016605A1 DE102004016605A DE102004016605A DE102004016605A1 DE 102004016605 A1 DE102004016605 A1 DE 102004016605A1 DE 102004016605 A DE102004016605 A DE 102004016605A DE 102004016605 A DE102004016605 A DE 102004016605A DE 102004016605 A1 DE102004016605 A1 DE 102004016605A1
Authority
DE
Germany
Prior art keywords
dollar
thiocarbamoylproline
prophylaxis
tumors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102004016605A
Other languages
German (de)
Inventor
Werner Mederski
Christos Tsaklakidis
Dieter Dorsch
Bertram Cezanne
Johannes Gleitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE102004016605A priority Critical patent/DE102004016605A1/en
Priority to PCT/EP2005/002745 priority patent/WO2005097783A1/en
Publication of DE102004016605A1 publication Critical patent/DE102004016605A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Neue Verbindungen der Formel I, DOLLAR F1 worin DOLLAR A R, R·1·, R·2·, R·3· und R·4· die in Patentanspruch 1 angegebene Bedeutung haben, DOLLAR A sind Inhibitoren des Koagulationsfaktors Xa und können zur Prophylaxe und/oder Therapie von thromboembolischen Erkrankungen und zur Behandlung von Tumoren eingesetzt werden.New compounds of the formula I, DOLLAR F1 in which DOLLAR AR, R · 1 ·, R · 2 ·, R · 3 · and R · 4 · have the meaning given in claim 1, DOLLAR A are inhibitors of the coagulation factor Xa and can be used for prophylaxis and / or therapy of thromboembolic disorders and for the treatment of tumors.

DE102004016605A 2004-04-03 2004-04-03 Thiocarbamoylproline Withdrawn DE102004016605A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE102004016605A DE102004016605A1 (en) 2004-04-03 2004-04-03 Thiocarbamoylproline
PCT/EP2005/002745 WO2005097783A1 (en) 2004-04-03 2005-03-15 Thiocarbamoylprolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004016605A DE102004016605A1 (en) 2004-04-03 2004-04-03 Thiocarbamoylproline

Publications (1)

Publication Number Publication Date
DE102004016605A1 true DE102004016605A1 (en) 2005-10-20

Family

ID=34963324

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004016605A Withdrawn DE102004016605A1 (en) 2004-04-03 2004-04-03 Thiocarbamoylproline

Country Status (2)

Country Link
DE (1) DE102004016605A1 (en)
WO (1) WO2005097783A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508101A (en) * 1998-04-10 2002-12-20 Japan Tobacco Inc Amidine compounds useful as factor Xa inhibitors and as anticoagulants
US7030141B2 (en) * 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
DE502004003688D1 (en) * 2003-04-03 2007-06-14 Merck Patent Gmbh PYRAZOLIDINE-1,2-DICARBOXYLIC ACID-1 - ((PHENYL) -AMID) -2 - ((PHENYL) -AMID) DERIVATIVES AS COAGULATION FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBOSES
JP5015593B2 (en) * 2003-06-18 2012-08-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis

Also Published As

Publication number Publication date
WO2005097783A8 (en) 2007-04-19
WO2005097783A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
TW200512200A (en) Carbonyl compounds
NO20060541L (en) Pinerazine with OR-substituted phenyl grounds and their use as GlyT1 inhibitors
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
ATE543819T1 (en) HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF AND TREATMENT METHODS THEREOF
DE60231804D1 (en) USE OF HEPCIDINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF IRON HOMEOSTASTE DISORDER
TW200800975A (en) New compounds 2
TW200504012A (en) Ethynylproline derivatives
DE602006010834D1 (en) NEW THIOPHENSULFOXIMINE FOR THE TREATMENT OF COMPLEMENTED DISEASES AND SUFFERING
ATE553198T1 (en) TREATMENT OF CANCER THROUGH THE COMBINED INHIBITION OF PROTEASOME AND TELOMERASE ACTIVITIES
EA200600689A1 (en) SUBSTITUTED BENZEZOLES AND THEIR APPLICATION AS RAF KINASE INHIBITORS
TW200637866A (en) Amino-imidazolones for the inhibition of β-secretase
ATE492542T1 (en) PREPARATION AND USE OF BIPHENYL-4-YL CARBONYLAMINOSIC ACID DERIVATIVES FOR THE TREATMENT OF OBESITAS
ATE544748T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELL PROLIFERATION DISEASES
ATE459615T1 (en) 2-PYRIDONE DERIVATIVES FOR THE TREATMENT OF ILLNESSES OR CONDITIONS IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL
DE602005019078D1 (en) PIPERIDINE AND RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER DISEASE
DE502004005033D1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSIONS
ATE464308T1 (en) STEREOISOMERIC COMPOUNDS AND METHODS FOR TREATING DISEASES OF THE GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM
WO2005123660A3 (en) Polycationic compounds and uses thereof
NO20074360L (en) Treatment of metastatic tumors
NO20055741L (en) New chemical compounds
UA85676C2 (en) Carbonyl compounds
ATE451361T1 (en) MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS
ATE530525T1 (en) PIPERIDINE AND RELATED COMPOUNDS FOR THE TREATMENT OF DEMENTIA
EA200800374A1 (en) 1,4-DIHYDROPYRIDIN-CONDENSED HETEROCYCLES, METHODS FOR THEIR PRODUCTION, USE AND CONTAINING COMPOSITIONS
DE60036122D1 (en) USE OF EPLERENONE FOR THE TREATMENT OF RESTENOSIS

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee